Skip to content
see continuation on the next page
Since 2021, various associations and health experts have been raising the alarm about a worrying increase in the incidence of several diseases: atypical cancers, neurological disorders, autoimmune diseases, and heart disease. While some hospital departments have observed this increase, they are hesitant to discuss it publicly. The available data speaks for itself. Reports indicate that COVID-19 vaccines account for 12% of global pharmacovigilance, and nearly 12,000 studies are currently underway to investigate possible links with various diseases. In France, the National Agency for the Safety of Medicines recorded no fewer than 193,934 reports of adverse effects, including 1,635 deaths, in its June 2023 report. These figures, based on a passive pharmacovigilance system, likely underestimate the reality considerably, according to many observers
